ScreenPoint Medical
AI-powered breast cancer detection and risk assessment solutions.
We may earn a commission from links on this ScreenPoint Medical profile. That does not change the facts we publish.
About
ScreenPoint Medical is a Nijmegen-based company specializing in AI-powered technology for breast cancer detection and risk assessment. Their solutions aim to improve consistency, reduce uncertainty, enhance the patient experience, and deliver personalized medicine across the entire breast imaging continuum. Their flagship product, Transpara, assists radiologists in analyzing mammograms for early diagnosis. Teams look it up for HealthTech, Artificial Intelligence, Medical Devices.
Frequently asked
What does ScreenPoint Medical do?
ScreenPoint Medical is a HealthTech company that offers Software. Teams look it up for Artificial Intelligence, Medical Devices, Biotechnology. It is based in Nijmegen, North Brabant, Netherlands and was founded in 2014. Public records show about 79 people and $30M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has ScreenPoint Medical raised?
ScreenPoint Medical has raised a total of $30M in funding. The most recent round on record is Grant.
Where is ScreenPoint Medical headquartered?
ScreenPoint Medical is headquartered in Nijmegen, North Brabant, Netherlands.
When was ScreenPoint Medical founded?
ScreenPoint Medical was founded in 2014.
What industry does ScreenPoint Medical operate in?
ScreenPoint Medical operates in HealthTech, Artificial Intelligence, Medical Devices, Biotechnology, MedTech.
How many employees does ScreenPoint Medical have?
ScreenPoint Medical has approximately 79 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.